Biologics are medications made using living organisms. Biosimilars mimic FDA-approved biologics but may vary in their inactive ingredients.
Biologics and biosimilar medications are a newer form of therapy. Doctors use them to treat, prevent, or cure several conditions, including diabetes, cancer, kidney disease, and various autoimmune diseases.
Creating biologics involves a more complicated process than producing small molecule medications with chemicals.
This article reviews biologics and biosimilar medications and includes information on their use, manufacturing, safety, and effectiveness.
Biologics are effective and specialized medications made from living cells and organisms. Biosimilars work much like biologics, to the point where doctors can sometimes use them interchangeably.
Biologics can take several forms, including:
- cell therapies
- gene therapies
- therapeutic proteins
- monoclonal antibodies
Doctors often use biologics in treating, preventing, or slowing the progress of several conditions or diseases, such as:
- autoimmune disorders
- cystic fibrosis
- chronic kidney disease
- inflammatory bowel disease (IBD)
The Food and Drug Administration (FDA)
However, biologics are larger and more complex to develop than small molecule medications. Doctors also typically administer them through infusions or injections.
According to the
- how doctors administer them
- potential side effects
- dosage and strength
Some biosimilars are interchangeable. With interchangeable biosimilars, a pharmacist can dispense the biosimilar in place of the prescribed biologic.
In short, biosimilars can provide the same treatment effects but are generally easier to develop than the biologics they imitate.
In medication, the term “generic” typically refers to non-branded versions of a given medication.
For example, a person needing a pain reliever can choose between Tylenol and a generic store-brand version of acetaminophen. The two medications are identical on a molecular level.
Biologics are a lot more complex and challenging to produce and reproduce. To complicate things further, biologics can differ in potency and makeup among batches at the same manufacturer.
This means that biosimilars are not generic medications in the traditional sense. Instead, they are a similar alternative to the original biologic.
A doctor needs to prescribe a biosimilar specifically, and a pharmacist cannot substitute most biosimilars for biologics without consent from a doctor as they can with generic medications.
According to researchers from Johns Hopkins, the complexity associated with manufacturing biologics has made many people question whether generic versions would work. However, they noted in 2016 that generic versions of biologics, also known as biosimilars, could provide the same benefits and quality as the original biologic.
Biologics come in several different forms or types. Doctors can use biologics to treat, prevent, or cure a variety of conditions and diseases.
- blood and blood components
- recombinant therapeutic proteins
- somatic cells
- gene therapy
Some examples include:
- anakinra (Kineret)
- tocilizumab (Actemra)
- abatacept (Orencia)
- golimumab (Simponi)
- adalimumab (Humira)
- certolizumab pegol (Cimzia)
- rituximab (Rituxan or MabThera)
- etanercept (Enbrel)
- infliximab (Remicade)
Biologics may be made of cells from microorganisms, animals, or humans. They may also be made up of nucleic acids, proteins, sugars, or a combination of these compounds.
Manufacturers create biosimilars to be virtually identical to the referenced biologic. This means they
- doses and strengths
- potential for side effects
As of October 2021, there were 21 biosimilars on the market in the United States competing against eight referenced biologics. Additionally, there are roughly 100 biosimilars in development.
In short, a doctor can prescribe a biosimilar in place of a biologic as long as it can treat the same condition and has FDA approval.
Biologics and biosimilars can treat conditions such as cancer, multiple sclerosis, and other difficult-to-treat conditions.
At the pharmacy
According to the
This means a pharmacist can substitute the interchangeable biosimilar medication for the referenced biologic without requiring approval from the prescribing doctor, although rules may vary among states. However, the prescribing doctor needs to have specified the drug’s function.
The future: Could biosimilars replace biologics?
The market for biosimilars has grown with the general success of and demand for biologics. Biosimilars open the door for people to get biologic treatment for chronic diseases when traditional medications do not provide enough relief.
According to the
Biosimilars will likely increase in numbers in the coming years, especially as patents expire for existing biologics. This process mimics that of traditional medications. When a brand name drug goes off patent, a less expensive generic usually becomes available.
However, as the
In addition, biologics and biosimilars can cause some severe side effects. According to an older 2011 research review, the use of biologics and biosimilars might increase a person’s risk of developing certain side effects, including:
- serious illness
- congestive heart failure
However, the authors of the review also noted that people taking the biologics or biosimilar medications over a short period had no greater risk of serious side effects than people taking placebos.
Many doctors will recommend biologics because of how effective they can be in treating certain conditions.
According to the
Biosimilars have the same
Biologics and biosimilars can offer advanced care for people living with different medical conditions, including cancer, multiple sclerosis, and psoriatic arthritis. However, they may not work for everyone.
The following are some pros and cons a person may wish to discuss with their doctor.
Biologics and biosimilars are effective forms of medication that use living cells and organisms to treat, cure, or prevent certain conditions. Doctors can prescribe either a biologic or available biosimilar medication for treatment.
Though biosimilars involve the same effects, doses, and safety as biologics, they are often lower in price.